BACKGROUND: Limited information is available on the potential link between obesity and either melanoma or non-melanoma skin cancers. OBJECTIVE: To conduct a prospective study to examine the association between obesity and the risk of both melanoma and non-melanoma skin cancers. METHODS: Using pooled data from two large national cohorts in the US, the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS), we prospectively examined the incidence of melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) among participants grouped according to body mass index (BMI). RESULTS: Compared to participants with an updated BMI in the normal range, those with a BMI in the obese range had a 32 % lower risk of developing SCC, and those with a BMI in the morbidly obese category had a 37 % lower risk of developing SCC. The decrease in SCC risk was limited to women. Compared to participants with a BMI in the normal range, those with a BMI in the obese range had a 19 % lower risk of developing BCC, and those with a BMI in the morbidly obese category had a 29 % lower risk of developing BCC. The risk of developing melanoma did not statistically differ by BMI grouping. The results were similar using BMI measurements obtained 10 years prior to the diagnosis of skin cancer. CONCLUSION: Obesity appears to be inversely associated with the development of non-melanoma skin cancers. Obesity is most likely a surrogate marker for lack of chronic sun exposure, which is a risk factor for non-melanoma skin cancers.
BACKGROUND: Limited information is available on the potential link between obesity and either melanoma or non-melanoma skin cancers. OBJECTIVE: To conduct a prospective study to examine the association between obesity and the risk of both melanoma and non-melanoma skin cancers. METHODS: Using pooled data from two large national cohorts in the US, the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS), we prospectively examined the incidence of melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) among participants grouped according to body mass index (BMI). RESULTS: Compared to participants with an updated BMI in the normal range, those with a BMI in the obese range had a 32 % lower risk of developing SCC, and those with a BMI in the morbidly obese category had a 37 % lower risk of developing SCC. The decrease in SCC risk was limited to women. Compared to participants with a BMI in the normal range, those with a BMI in the obese range had a 19 % lower risk of developing BCC, and those with a BMI in the morbidly obese category had a 29 % lower risk of developing BCC. The risk of developing melanoma did not statistically differ by BMI grouping. The results were similar using BMI measurements obtained 10 years prior to the diagnosis of skin cancer. CONCLUSION:Obesity appears to be inversely associated with the development of non-melanoma skin cancers. Obesity is most likely a surrogate marker for lack of chronic sun exposure, which is a risk factor for non-melanoma skin cancers.
Authors: Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal Journal: JAMA Date: 2004-06-16 Impact factor: 56.272
Authors: Kate A Scott; Robert J Moore; Caroline H Arnott; Nick East; Richard G Thompson; Bernard J Scallon; David J Shealy; Frances R Balkwill Journal: Mol Cancer Ther Date: 2003-05 Impact factor: 6.261
Authors: Sang Min Park; Tricia Li; Shaowei Wu; Wen-Qing Li; Martin Weinstock; Abrar A Qureshi; Eunyoung Cho Journal: Int J Cancer Date: 2017-02-14 Impact factor: 7.396
Authors: Jamie J Bernard; You-Rong Lou; Qing-Yun Peng; Tao Li; Priyal R Vakil; Ning Ding; Jeffrey D Laskin; Zigang Dong; Allan H Conney; Yao-Ping Lu Journal: J Carcinog Mutagen Date: 2014-07-31
Authors: Jean Claude Dusingize; Catherine M Olsen; Jiyuan An; Nirmala Pandeya; Matthew H Law; Bridie S Thompson; Alisa M Goldstein; Mark M Iles; Penelope M Webb; Rachel E Neale; Jue-Sheng Ong; Stuart MacGregor; David C Whiteman Journal: Int J Epidemiol Date: 2020-08-01 Impact factor: 7.196
Authors: Jean Y Tang; Michael T Henderson; Tina Hernandez-Boussard; Jessica Kubo; Manisha Desai; Stacy T Sims; Vanita Aroda; Fridtjof Thomas; Anne McTiernan; Marcia L Stefanick Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-16 Impact factor: 4.254
Authors: Mark M Iles; Matthew H Law; Simon N Stacey; Jiali Han; Shenying Fang; Ruth Pfeiffer; Mark Harland; Stuart Macgregor; John C Taylor; Katja K Aben; Lars A Akslen; Marie-Françoise Avril; Esther Azizi; Bert Bakker; Kristrun R Benediktsdottir; Wilma Bergman; Giovanna Bianchi Scarrà; Kevin M Brown; Donato Calista; Valérie Chaudru; Maria Concetta Fargnoli; Anne E Cust; Florence Demenais; Anne C de Waal; Tadeusz Dębniak; David E Elder; Eitan Friedman; Pilar Galan; Paola Ghiorzo; Elizabeth M Gillanders; Alisa M Goldstein; Nelleke A Gruis; Johan Hansson; Per Helsing; Marko Hočevar; Veronica Höiom; John L Hopper; Christian Ingvar; Marjolein Janssen; Mark A Jenkins; Peter A Kanetsky; Lambertus A Kiemeney; Julie Lang; G Mark Lathrop; Sancy Leachman; Jeffrey E Lee; Jan Lubiński; Rona M Mackie; Graham J Mann; Nicholas G Martin; Jose I Mayordomo; Anders Molven; Suzanne Mulder; Eduardo Nagore; Srdjan Novaković; Ichiro Okamoto; Jon H Olafsson; Håkan Olsson; Hubert Pehamberger; Ketty Peris; Maria Pilar Grasa; Dolores Planelles; Susana Puig; Joan Anton Puig-Butille; Juliette Randerson-Moor; Celia Requena; Licia Rivoltini; Monica Rodolfo; Mario Santinami; Bardur Sigurgeirsson; Helen Snowden; Fengju Song; Patrick Sulem; Kristin Thorisdottir; Rainer Tuominen; Patricia Van Belle; Nienke van der Stoep; Michelle M van Rossum; Qingyi Wei; Judith Wendt; Diana Zelenika; Mingfeng Zhang; Maria Teresa Landi; Gudmar Thorleifsson; D Timothy Bishop; Christopher I Amos; Nicholas K Hayward; Kari Stefansson; Julia A Newton Bishop; Jennifer H Barrett Journal: Nat Genet Date: 2013-03-03 Impact factor: 38.330